首页> 美国卫生研究院文献>International Journal of Molecular Medicine >Identification of novel hyper- or hypomethylated CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide association study
【2h】

Identification of novel hyper- or hypomethylated CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide association study

机译:使用表观基因组范围的关联研究鉴定新的高甲基化或低甲基化的CpG位点和与动脉粥样硬化斑块相关的基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

DNA methylation is an important epigenetic modification that has been implicated in the pathogenesis of atherosclerosis. Although previous studies have identified various CpG sites and genes whose methylation is associated with atherosclerosis in populations with European or Mexican ancestry, the genome-wide pattern of DNA methylation in the atherosclerotic human aorta is yet to be elucidated in Japanese individuals. In the present study, a genome-wide analysis of DNA methylation at ~853,000 CpG sites was performed using 128 postmortem aortic intima specimens obtained from 64 Japanese patients. To avoid the effects of interindividual variation, intraindividual paired comparisons were performed between atheromatous plaque lesions and corresponding plaque-free tissue for each patient. Bisulfite-modified genomic DNA was analyzed using a specific microarray for DNA methylation. DNA methylation at each CpG site was calculated as the β value, where β = (intensity of the methylated allele)/(intensity of the methylated allele + intensity of the unmethylated allele + 100). Bonferroni's correction for statistical significance of association was applied to compensate for multiple comparisons. The methylation of 2,679 CpG sites differed significantly (P<5.86×10−8) between atheromatous plaque lesions and the corresponding plaque-free intima, with 2,272 and 407 CpG sites in atheromatous plaques being hyper- or hypomethylated, respectively. A total of 5 hypermethylated CpG sites in atheromatous plaques were demonstrated to have a difference in β value of >0.15 (plaque lesion-plaque-free intima) and 11 had a β ratio of >1.50 (plaque/plaque-free intima). A further 15 and 17 hypomethylated CpG sites in atheromatous plaques were observed to have a difference in β value of <−0.15 or a β ratio of <0.67, respectively. According to these limits, a total of 16 novel genes that were significantly hyper- or hypomethylated in atheromatous plaque lesions compared with the plaque-free intima were identified in the present study. The results of the present study suggest that the methylation of these genes may contribute to the pathogenesis of atherosclerosis in the Japanese population.
机译:DNA甲基化是一种重要的表观遗传修饰,已与动脉粥样硬化的发病机理有关。尽管先前的研究已经确定了在欧洲或墨西哥血统的人群中甲基化与动脉粥样硬化相关的各种CpG位点和基因,但日本人尚不清楚动脉粥样硬化人类主动脉中全基因组DNA甲基化的模式。在本研究中,使用从64位日本患者中获得的128个死后主动脉内膜标本,对〜853,000 CpG位点的DNA甲基化进行了全基因组分析。为了避免个体差异的影响,对每个患者在动脉粥样斑块病变和相应的无斑块组织之间进行了个体配对比较。使用特定的微阵列对亚硫酸氢盐修饰的基因组DNA进行DNA甲基化分析。计算每个CpG位点的DNA甲基化为β值,其中β=(甲基化等位基因的强度)/(甲基化等位基因的强度+未甲基化等位基因的强度+100)。使用Bonferroni对关联的统计显着性的校正来补偿多重比较。动脉粥样硬化斑块病变和相应的无斑块内膜之间的2679个CpG位点的甲基化差异显着(P <5.86×10 -8 ),其中动脉粥样斑块的2272和407个CpG位点甲基化程度过高或过低, 分别。动脉粥样硬化斑块中总共有5个高甲基化CpG位点的β值差异大于0.15(无斑块病变的内膜),有11个β比率大于1.50(无斑块/无斑块的内膜)。观察到粥样斑块中的另外15个和17个低甲基化的CpG位点的β值差异分别为<-0.15或β比率为<0.67。根据这些限制,在本研究中鉴定出总共16个在动脉粥样斑块病变中与无斑块内膜相比明显甲基化或甲基化不足的新基因。本研究的结果表明,这些基因的甲基化可能有助于日本人群中动脉粥样硬化的发病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号